In vivo tissue-tropism of adeno-associated viral vectors

A Srivastava - Current opinion in virology, 2016 - Elsevier
Highlights•AAV is a non-pathogenic virus, and recombinant AAV vectors have proven to be
highly efficient for gene delivery to a wide variety of cell types, tissue, and organs in small …

Cystic fibrosis gene therapy: looking back, looking forward

AL Cooney, PB McCray Jr, PL Sinn - Genes, 2018 - mdpi.com
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene that encodes a cAMP …

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage …

N Kaludov, KE Brown, RW Walters, J Zabner… - Journal of …, 2001 - Am Soc Microbiol
Adeno-associated virus serotype 4 (AAV4) and AAV5 have different tropisms compared to
AAV2 and to each other. We recently reported that α2-3 sialic acid is required for AAV5 …

[HTML][HTML] Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape

RW Walters, P Freimuth, TO Moninger, I Ganske… - Cell, 2002 - cell.com
Adenovirus binds its receptor (CAR), enters cells, and replicates. It must then escape to the
environment to infect a new host. We found that following infection, human airway epithelia …

Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus

D Duan, Y Yue, Z Yan, J Yang… - The Journal of clinical …, 2000 - Am Soc Clin Investig
The restriction of viral receptors and coreceptors to the basolateral surface of airway
epithelial cells has been blamed for the inefficient transfer of viral vectors to the apical …

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

D Grimm, MA Kay - Current gene therapy, 2003 - ingentaconnect.com
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …

AAV capsid structure and cell interactions

M Agbandje-McKenna, J Kleinschmidt - Adeno-associated virus: methods …, 2011 - Springer
Abstract The Adeno-associated viruses (AAVs) are not associated with any diseases, and
their ability to package non-genomic DNA and to transduce different cell/tissue populations …

Binding of adeno-associated virus type 5 to 2, 3-linked sialic acid is required for gene transfer

RW Walters, SMP Yi, S Keshavjee, KE Brown… - Journal of Biological …, 2001 - ASBMB
Recombinant adeno-associated viruses (AAV) are promising gene therapy vectors.
Whereas AAV serotype 2-mediated gene transfer to muscle has partially replaced factor IX …

Gene therapy for cystic fibrosis: Challenges and prospects

H Sui, X Xu, Y Su, Z Gong, M Yao, X Liu… - Frontiers in …, 2022 - frontiersin.org
Cystic fibrosis (CF) is a life-threatening autosomal-recessive disease caused by mutations in
a single gene encoding cystic fibrosis transmembrane conductance regulator (CFTR). CF …

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells

T Chirkova, S Lin, AGP Oomens… - Journal of General …, 2015 - microbiologyresearch.org
Respiratory syncytial virus (RSV) is a major cause of severe pneumonia and bronchiolitis in
infants and young children, and causes disease throughout life. Understanding the biology …